Neil Voskoboynikov serves as a Distinguished Engineer in the Research and Development department at Medtronic, where he plays a pivotal role in advancing catheter-based technologies for Percutaneous Coronary Intervention (PCI) and Renal Denervation (RDN) biosignal diagnostics and neuromodulation therapies. With a robust background in engineering...
Neil Voskoboynikov serves as a Distinguished Engineer in the Research and Development department at Medtronic, where he plays a pivotal role in advancing catheter-based technologies for Percutaneous Coronary Intervention (PCI) and Renal Denervation (RDN) biosignal diagnostics and neuromodulation therapies. With a robust background in engineering research and clinical applications, Neil is adept at navigating the complexities of product realization from ideation through to commercialization within diverse organizational structures, including start-ups, mid-sized firms, and Fortune 500 companies.
In his current role, Neil is instrumental in roadmap development, ensuring that innovative solutions align with user needs and market demands. He leads proof-of-concept and feasibility testing, driving the prototyping process to validate new technologies. His expertise extends to conducting thorough due diligence, managing intellectual property, and fostering strategic partnerships that enhance Medtronic's competitive edge in the cardiovascular space.
Neil's comprehensive skill set encompasses design control, validation, and quality systems, all while adhering to ISO 13485 standards. His leadership in clinical research and CAPA processes underscores his commitment to delivering safe and effective medical devices. Furthermore, Neil is passionate about mentoring emerging talent, sharing his knowledge to cultivate the next generation of engineers in the cardiology field. His unique blend of technical acumen and collaborative spirit positions him as a key contributor to Medtronic's mission to transform patient care through innovative medical technologies.
